Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.

Slides:



Advertisements
Similar presentations
What to do when basal bolus therapy fails in Type 2 Diabetes [insert name] UKHMG00596a February 2012 Prescribing information can be found on the last slide.
Advertisements

UKPDS Paper 36 Slides © University of Oxford Diabetes Trials Unit UKPDS slides are copyright and remain the property of the University of Oxford Diabetes.
UKPDS Paper 35 Slides © University of Oxford Diabetes Trials Unit
FDA Endocrinologic and Metabolic Drugs Advisory Committee 1st June 2008 Rury Holman Clinical outcomes with anti-diabetic drugs: What we already know.
Consider testing if person is: – Overweight or obese with additional risk factor for diabetes – Age 45 or older Obtain: A1C or FPG or 2-hour plasma glucose.
Date of download: 6/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Major Lipids, Apolipoproteins, and Risk of Vascular.
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study  Dr Jack R W Brownrigg,
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
Copyright © 2014 American Medical Association. All rights reserved.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Copyright © 2007 American Medical Association. All rights reserved.
Pravastatin in Elderly Individuals at Risk of Vascular Disease
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.
Association of blood lipids with AF
Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,
Cardiovascular risk factors: are they useful screening tests?
Association of low eosinophil and lymphocyte counts with different initial presentations of cardiovascular disease over the first 6 months ‘Low eosinophils’
366 میلیون نفر در جهان مبتلا به دیابت هستند.
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure  Anna Gu, MD, PhD, Yu Yue, PhD, Joohae Kim, PharmD Candidate, Edgar.
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Prospective Studies Collaboration Lancet 2009; 373:
Joshua A. Bell et al. JACC 2018;72:
Dileep Raman et al. JACEP 2017;3:
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Wesley T. O’Neal et al. JACEP 2016;2:
Associations of Coffee, Tea, and Caffeine Intake with Coronary Artery Calcification and Cardiovascular Events  P. Elliott Miller, MD, Di Zhao, PhD, Alexis.
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy  Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.
Volume 81, Issue 3, Pages (February 2012)
Volume 79, Issue 12, Pages (June 2011)
Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome  Jonas Faxén, Hong Xu,
Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.
The Clock is ticking for the world’s leaders
Connie W. Tsao et al. JCHF 2016;4:
Characteristics of Study Subjects and Events, According to the Quintile of Exposure to Fine Particulate Matter (PM2.5)* - Part I Kristin A. Miller et al.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.
Characteristics of included studies
Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Lars E. Laugsand et al. BTS 2016;j.jacbts
Flow chart of search strategy
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Volume 75, Issue 1, Pages (January 2009)
Connie W. Tsao et al. JCHF 2016;4:
Associations between type of MI and incident HF
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Knowledge gaps in key risk factor numbers
Increase of physical activity over time associated with lower HF risk
Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Risk of venous thromboembolism by ABO blood type, factor V Leiden R506Q and prothrombin G20210A mutations among individuals in the Copenhagen General.
Figure 2. Associations of comorbidities with PD in elderly participants in the multivariate regression analysis. The multivariate Cox proportional-hazards.
Odds ratio (95% confidence intervals) of reporting respiratory symptoms in patients with treated hypothyroidism or inflammatory bowel disease (IBD) compared.
HR for mortality in ischemic heart disease.
Representativeness of linked cancer registry and dispensed prescription data as compared with cancer registry data alone, by key patient and tumour characteristics.
HR for myocardial infarction.
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.
Forest plot showing survival c-statistics for selected models, applied to the testing cohort. Forest plot showing survival c-statistics for selected models,
A – Demographic, Anthropometric and Clinical correlates of plasma NT-proBNP levels stratified by race: Multivariable Regression Results (Multivariable.
Receiver operating characteristic curve showing results for two selected models, applied to the testing cohort. Receiver operating characteristic curve.
Presentation transcript:

Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration and myocardial infarction, stroke, microvascular end points, cataract extraction, lower extremity amputation or fatal peripheral vascular disease, and heart failure. Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration and myocardial infarction, stroke, microvascular end points, cataract extraction, lower extremity amputation or fatal peripheral vascular disease, and heart failure. Reference category (hazard ratio 1.0) is haemoglobin A1c <6% with log linear scales. P value reflects contribution of glycaemia to multivariate model. Data adjusted for age at diagnosis of diabetes, sex, ethnic group, smoking, presence of albuminuria, systolic blood pressure, high and low density lipoprotein cholesterol, and triglycerides Irene M Stratton et al. BMJ 2000;321:405-412 ©2000 by British Medical Journal Publishing Group